Patients with prior treatment for diabetic macular edema (DME) may require more frequent dosing of aflibercept (Eylea), according to a subgroup analysis of the PHOTON trial presented at the recent ...

EyePoint Pharmaceuticals' Duravyu shows promising Phase 2 results in DME, with potential for less frequent dosing. Check out ...

Reporter Will Weissert’s takeaway from that conversation was to take a direct, critical look at some of Trump’s most eye-popping statements and proposals—and track where they stand now. As he dug into ...

to be followed by a standard injection of Roche's (ROG.S), opens new tab Avastin (bevacizumab) into the clear gel-like area that fills the eye between the lens and retina. After that initial four ...

Such a decision will also significantly reduce the frequency of injections and clinic ... Please note that Eylea is a blockbuster drug for treating retinal eye diseases. Eylea 8 mg is currently ...

Having shown no neurological symptoms in the decades since the injection, the 58-year-old recently ... difficulty speaking and abnormal breathing. After being admitted to hospital, she entered ...

It took place just five months after having an elective surgery ... “On the ride home, he kept saying about how, ‘Something’s not right with my right eye,’” Tim Kingerski remembered. “And I said, ...

It took place just five months after having an elective surgery ... ‘Something’s not right with my right eye,’” Tim Kingerski remembered. “And I said, ‘What do you mean?’ ...

Similar to Eylea, Vabysmo is approved for a range of retinal diseases but has higher uptake due to the longer intervals between injections. Vabysmo generated ... first bispecific antibody approved for ...